Comparison of the telephone-Montreal Cognitive Assessment (T-MoCA) and Telephone Interview for Cognitive Status (TICS) as screening tests for early Alzheimer's disease.
Comparison of the telephone-Montreal Cognitive Assessment (T-MoCA) and Telephone Interview for Cognitive Status (TICS) as screening tests for early Alzheimer's disease.
复制标题
蒙特利尔电话认知评估 (T-MoCA) 和认知状态电话访谈 (TICS) 作为早期阿尔茨海默病筛查测试的比较。
DOI:
10.1002/alz.13039
复制
发表时间:
2023
期刊:
影响因子:
--
通讯作者:
Salmon,DavidP
中科院分区:
文献类型:
--
作者:
Chappelle,SheridanD;Gigliotti,Christina;Léger,GabrielC;Peavy,GuerryM;Jacobs,DianeM;Banks,SarahJ;Little,EmilyA;Galasko,Douglas;Salmon,DavidP
IntroductionRemote screening for cognitive impairment associated with Alzheimer's disease (AD) has grown in importance with the expected rise in prevalence of AD in an aging population and with new potential treatment options.MethodsThe Telephone Interview for Cognitive Status (TICS) and new telephone adaptation of the Montreal Cognitive Assessment (T‐MoCA) were administered to participants independently classified through in‐person clinical evaluation as cognitively normal (CN;n= 167), mild cognitive impairment (MCI;n= 25), or dementia (n= 23). Cerebrospinal fluid AD biomarkers were measured (n= 79).ResultsTICS and T‐MoCA were highly correlated (r= 0.787;P< 0.001): groups differed on both (CN<MCI<dementia; TICS:F[2212] = 156.66;P< 0.001; T‐MoCA:F[2210] = 143.72;P< 0.001), both effectively detected cognitive impairment (receiver operating characteristic area under the curve: TICS = 0.889; T‐MoCA = 0.902), and both negatively correlated with a composite AD biomarker (tau/amyloid beta 1‐42; TICS:r= −0.372;P= 0.001; T‐MoCA:r= −0.480;P< 0.001).DiscussionTICS and T‐MoCA are effective for remotely detecting cognitive impairment associated with AD in older adults. Strong correlation between tests provides construct validity for the newer T‐MoCA.HighlightsConstruct validity for the telephone adaptation of the Montreal Cognitive Assessment (T‐MoCA) was newly established against the Telephone Interview for Cognitive Status (TICS).TICS and T‐MoCA effectively detected cognitive impairment with remote administration.Both tests negatively correlated with a composite cerebrospinal fluid Alzheimer's disease (AD) biomarker (tau/amyloid beta 1‐42).